Int J Stomatol ›› 2023, Vol. 50 ›› Issue (5): 521-527.doi: 10.7518/gjkq.2023072
• Oral Oncology • Previous Articles Next Articles
CLC Number:
1 | Johnson DE, Burtness B, Leemans CR, et al. Author correction: head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2023, 9(1): 4. |
2 | Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. |
3 | Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. |
4 | Ferlito A, Rinaldo A, Robbins KT, et al. Changing concepts in the surgical management of the cervical node metastasis[J]. Oral Oncol, 2003, 39(5): 429-435. |
5 | Sharma D, Koshy G, Grover S, et al. Sentinel Lymph node biopsy: a new approach in the management of head and neck cancers[J]. Sultan Qaboos Univ Med J, 2017, 17(1): e3-e10. |
6 | Chikamatsu K, Kamada H, Ninomiya H, et al. A preliminary study on sentinel lymph node biopsy: feasibility and predictive ability in oral cavity cancer[J]. Ann Nucl Med, 2004, 18(3): 257-262. |
7 | Hanai N, Asakage T, Kiyota N, et al. Controversies in relation to neck management in N0 early oral tongue cancer[J]. Jpn J Clin Oncol, 2019, 49(4): 297-305. |
8 | Ho CM, Lam KH, Wei WI, et al. Occult lymph node metastasis in small oral tongue cancers[J]. Head Neck, 1992, 14(5): 359-363. |
9 | van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria[J]. Radiology, 1990, 177(2): 379-384. |
10 | Suzuki S, Honda K, Nanjo H, et al. CD147 expression correlates with lymph node metastasis in T1-T2 squamous cell carcinoma of the tongue[J]. Oncol Lett, 2017, 14(4): 4670-4676. |
11 | Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx[J]. Laryngoscope, 2001, 111(6): 1079-1087. |
12 | Calabrese L, Bruschini R, Ansarin M, et al. Role of sentinel lymph node biopsy in oral cancer[J]. Acta Otorhinolaryngol Ital, 2006, 26(6): 345-349. |
13 | Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial[J]. J Clin Oncol, 2010, 28(8): 1395-1400. |
14 | Alvarez Amézaga J, Barbier Herrero L, Pijoan del Barrio JI, et al. Diagnostic efficacy of sentinel node biopsy in oral squamous cell carcinoma. Cohort study and meta-analysis[J]. Med Oral Patol Oral Cir Bucal, 2007, 12(3): E235-E243. |
15 | Stefanicka P, Profant M, Duchaj B, et al. Sentinel lymph node radiolocalization and biopsy in oral ca-vity and oropharynx mucosal squamous cell carcinoma[J]. Bratisl Lek Listy, 2010, 111(11): 590-594. |
16 | den Toom IJ, Boeve K, Lobeek D, et al. Elective neck dissection or sentinel lymph node biopsy in early stage oral cavity cancer patients: the Dutch experience[J]. Cancers (Basel), 2020, 12(7): 1783. |
17 | de Bree R, Dankbaar JW, de Keizer B. New deve-lopments in sentinel lymph node biopsy procedure in localized oral cancer[J]. JAMA Otolaryngol Head Neck Surg, 2019, 145(8): 741-742. |
18 | Varghese P, Abdel-Rahman AT, Akberali S, et al. Methylene blue dye: a safe and effective alternative for sentinel lymph node localization[J]. Breast J, 2008, 14(1): 61-67. |
19 | Sangwan P, Nilakantan A, Patnaik U, et al. Sentinel lymph node localization using 1% isosulfan blue dye in cases of early oral cavity and oropharyngeal squamous cell carcinoma[J]. Indian J Otolaryngol Head Neck Surg, 2015, 67(): 56-61. |
20 | Vishnoi JR, Kumar V, Gupta S, et al. Outcome of sentinel lymph node biopsy in early-stage squamous cell carcinoma of the oral cavity with methylene blue dye alone: a prospective validation study[J]. Br J Oral Maxillofac Surg, 2019, 57(8): 755-759. |
21 | Niebling MG, Pleijhuis RG, Bastiaannet E, et al. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping[J]. Eur J Surg Oncol, 2016, 42(4): 466-473. |
22 | Subramanian S, Dandekar P, Jain R, et al. Technetium-99m-labeled poly(DL-lactide-co-glycolide) na-noparticles as an alternative for sentinel lymph node imaging[J]. Cancer Biother Radiopharm, 2010, 25(6): 637-644. |
23 | Jung SY, Kim SK, Kim SW, et al. Comparison of sentinel lymph node biopsy guided by the multimo-dal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope me-thod in breast cancer: a randomized controlled trial[J]. Ann Surg Oncol, 2014, 21(4): 1254-1259. |
24 | Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection-an overview[J]. Eur J Nucl Med, 1999, 26(4 ): S36-S42. |
25 | Brouwer OR, van den Berg NS, Mathéron HM, et al. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye[J]. Eur Urol, 2014, 65(3): 600-609. |
26 | Yamauchi K, Nagafuji H, Nakamura T, et al. Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye medical system[J]. Ann Surg Oncol, 2011, 18(7): 2042-2047. |
27 | Schaafsma BE, Mieog JS, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery[J]. J Surg Oncol, 2011, 104(3): 323-332. |
28 | Fujisawa Y, Nakamura Y, Kawachi Y, et al. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer[J]. J Surg Oncol, 2012, 106(1): 41-45. |
29 | Bredell MG. Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer-preliminary experience[J]. Head Neck Oncol, 2010, 2: 31. |
30 | Al-Dam A, Precht C, Barbe A, et al. Sensitivity and specificity of sentinel lymph node biopsy in patients with oral squamous cell carcinomas using indocyanine green fluorescence imaging[J]. J Craniomaxillofac Surg, 2018, 46(8): 1379-1384. |
31 | van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients[J]. Oral Oncol, 2013, 49(1): 15-19. |
32 | Nakamura T, Kogashiwa Y, Nagafuji H, et al. Validity of sentinel lymph node biopsy by ICG fluorescence for early head and neck cancer[J]. Anticancer Res, 2015, 35(3): 1669-1674. |
33 | Kågedal Å, Margolin G, Held C, et al. A novel sentinel lymph node approach in oral squamous cell carcinoma[J]. Curr Pharm Des, 2020, 26(31): 3834-3839. |
34 | Kim JH, Byeon HK, Kim DH, et al. ICG-guided sentinel lymph node sampling during robotic retroauricular neck dissection in cN0 oral cancer[J]. Otolaryngol Head Neck Surg, 2020, 162(3): 410-413. |
35 | Araki K, Mizokami D, Tomifuji M, et al. Novel indocyanine green-phytate colloid technique for sentinel node detection in head and neck: mouse study[J]. Otolaryngol Head Neck Surg, 2014, 151(2): 279-285. |
36 | Kogashiwa Y, Sakurai H, Akimoto Y, et al. Sentinel node biopsy for the head and neck using contrast-enhanced ultrasonography combined with indocyanine green fluorescence in animal models: a feasibility study[J]. PLoS One, 2015, 10(7): e0132511. |
37 | van Leeuwen AC, Buckle T, Bendle G, et al. Tracer-cocktail injections for combined pre-and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model[J]. J Biomed Opt, 2011, 16(1): 016004. |
38 | Cousins A, Thompson SK, Wedding AB, et al. Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging[J]. Biotechnol Adv, 2014, 32(2): 269-279. |
39 | Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents[J]. Chem Soc Rev, 2006, 35(6): 512-523. |
40 | Mekuria SL, Debele TA, Tsai HC. Encapsulation of gadolinium oxide nanoparticle (Gd2O3) contrasting agents in PAMAM dendrimer templates for enhanced magnetic resonance imaging in vivo [J]. ACS Appl Mater Interfaces, 2017, 9(8): 6782-6795. |
41 | Partridge SC, Kurland BF, Liu CL, et al. Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles[J]. Sci Rep, 2015, 5: 15641. |
42 | Loo BW Jr, Draney MT, Sivanandan R, et al. Indirect MR lymphangiography of the head and neck u-sing conventional gadolinium contrast: a pilot study in humans[J]. Int J Radiat Oncol Biol Phys, 2006, 66(2): 462-468. |
43 | Bae S, Lee HJ, Nam W, et al. MR lymphography for sentinel lymph node detection in patients with oral cavity cancer: preliminary clinical study[J]. Head Neck, 2018, 40(7): 1483-1488. |
44 | Choi SH, Moon WK. Contrast-enhanced MR ima-ging of lymph nodes in cancer patients[J]. Korean J Radiol, 2010, 11(4): 383-394. |
45 | Lu BL, Wang H, Lu Q, et al. Novel hybrid dextran-gadolinium nanoparticles as high-relaxivity T1 magnetic resonance imaging contrast agent for mapping the sentinel lymph node[J]. J Comput Assist Tomogr, 2019, 43(2): 350-357. |
[1] | Ji Xiao,Zhang Lan,Huang Dingming.. Diagnosis and treatment of odontogenic and non-odontogenic maxillary sinusitis [J]. Int J Stomatol, 2023, 50(5): 566-572. |
[2] | Jiang Yueying,He Yutian,Li Ting,Zhou Ronghui.. Research progress on the application of near infrared fluorescence probe in the diagnosis of oral cancer [J]. Int J Stomatol, 2023, 50(4): 407-413. |
[3] | Xia Weiyao,Luo Yankun,Jia Zhonglin. Review of the precise diagnosis and genetic etiology of Pierre Robin sequence [J]. Int J Stomatol, 2023, 50(3): 287-292. |
[4] | Qin Yichun,Tan Xuelian,Huang Dingming.. Clinical research progress on glandular odontogenic cyst [J]. Int J Stomatol, 2023, 50(1): 100-107. |
[5] | Li Ting,Yang Xuecai,Wang Junwei.. Children with Williams-Beuren syndrome associated with cranial and maxillofacial deformity [J]. Int J Stomatol, 2023, 50(1): 108-113. |
[6] | Li Weiguang,Wu Yafei,Guo Shujuan.. Research progress on the use of inorganic nanoparticles in the diagnosis and treatment of periodontal disease [J]. Int J Stomatol, 2022, 49(6): 724-730. |
[7] | Zhu Xingrong,Liao Lan. Research progress on oral clinical diagnosis and treatment of ectodermal dysplasia syndrome [J]. Int J Stomatol, 2022, 49(6): 737-742. |
[8] | Zeng Yanglin,Tan Xuelian,Song Dongzhe,Huang Dingming.. Research progress on diagnosis and treatment of root resorption [J]. Int J Stomatol, 2022, 49(5): 561-568. |
[9] | Yang Jiazhen,Zhang Ying,Liu Yuhan,Li Fan,Zeng Fei,Li Xiuzhen,Ma Yuying,Yang Fang. Time variation trend of bacterial community in oral diagnosis and treatment environment [J]. Int J Stomatol, 2022, 49(2): 132-137. |
[10] | Ye Zelin,Liu Lu,Long Hu,You Meng. Research progress on imaging evaluation and treatment of anterior dilacerated teeth [J]. Int J Stomatol, 2022, 49(2): 173-181. |
[11] | Dong Xu,Xu Xin. Research progress on cracked tooth [J]. Int J Stomatol, 2021, 48(6): 668-674. |
[12] | Meng Shuhuai,Luo Feng,Pei Xibo,Wan Qianbing. Research status on congenital syphilitic teeth [J]. Int J Stomatol, 2021, 48(4): 439-443. |
[13] | Tian Erkang,Xiang Qianrong,Zhao Xinran,Peng Jiahan,Shu Rui. Application of artificial intelligence in oral diagnosis and treatment [J]. Int J Stomatol, 2021, 48(4): 475-484. |
[14] | Fu Zhuohui,Tan Xuelian,Huang Dingming. Diagnosis and treatment of odontogenic maxillary sinusitis [J]. Int J Stomatol, 2021, 48(3): 367-372. |
[15] | Li Jiyao, Zheng Guangning. Spontaneous vertical root fracture: a diagnosis and treatment challenge [J]. Int J Stomatol, 2020, 47(4): 373-382. |